NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ModivCare Inc. (NASDAQ: MODV). Shareholders who purchased shares of MODV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news Investors who lost money on ModivCare Inc.(MODV) should contact The Gross Law Firm about pending Class Action - MODV

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of TELUS International (Cda) Inc. (NYSE: TIXT). Shareholders who purchased shares of TIXT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news The Gross Law Firm Reminds TELUS International (Cda) Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - TIXT

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE: NVO). Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news The Gross Law Firm Reminds Novo Nordisk A/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - NVO

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Capri Holdings Limited (NYSE: CPRI). Shareholders who purchased shares of CPRI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news Lost Money on Capri Holdings Limited(CPRI)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Transocean Ltd. (NYSE: RIG).

image for news Investors in Transocean Ltd. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - RIG

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cassava Sciences, Inc. (NASDAQ: SAVA). Shareholders who purchased shares of SAVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of MGP Ingredients, Inc. (NASDAQ: MGPI). Shareholders who purchased shares of MGPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 14, 2025 in MGP Ingredients, Inc. Lawsuit - MGPI

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI). Shareholders who purchased shares of KSPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news Joint Stock Company Kaspi.kz Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - KSPI

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news Investors who lost money on AstraZeneca PLC(AZN) should contact The Gross Law Firm about pending Class Action - AZN

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nextracker Inc. (NASDAQ: NXT). Shareholders who purchased shares of NXT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news Investors in Nextracker Inc. Should Contact The Gross Law Firm Before February 25, 2025 to Discuss Your Rights - NXT

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc.(RVNC) Shareholders

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Shareholders who purchased shares of REGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news The Gross Law Firm Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REGN

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU). Shareholders who purchased shares of CRBU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) should contact The Gross Law Firm about pending Class Action - CRBU

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news GSK plc Class Action: The Gross Law Firm Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSK

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Micron Technology, Inc. (NASDAQ: MU). Shareholders who purchased shares of MU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

image for news Micron Technology, Inc. Class Action: The Gross Law Firm Reminds Micron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - MU

Prediction: These 2 Vanguard ETFs Will Trounce the S&P 500 This Year — Positive

VFH  VOO  VOOG   The Motley Fool — February 10, 2025

Many Wall Street analysts think the S&P 500 will rise for the third consecutive year in 2025. Projections vary, but the consensus forecast appears to be that the index could jump in the ballpark of 10%.

image for news Prediction: These 2 Vanguard ETFs Will Trounce the S&P 500 This Year

Akebia Therapeutics: Still Bullish On Vafseo As Auryxia's Revenues Decline — Positive

AKBA   Seeking Alpha — February 10, 2025

Akebia Therapeutics is currently shifting focus from Auryxia to Vafseo due to Auryxia's declining revenues from patent expiration. Vafseo is now approved for dialysis patients and leverages AKBA's signature HIF pathway. So far, it has shown some early successes, which makes me optimistic. AKBA is also working on a Phase 3 trial for non‑dialysis CKD patients, which is scheduled for mid‑2025 to support a potential label expansion.

image for news Akebia Therapeutics: Still Bullish On Vafseo As Auryxia's Revenues Decline

SoFi Technologies: Maintaining Strong Buy On Macro Tailwinds — Positive

SOFI   Seeking Alpha — February 10, 2025

Delinquency rate growth is continuing to slow, creating a positive operating environment for SoFi. Refinancing demand exists, and SoFi is ready to capture the demand through its continued member growth and flywheel strategy. Despite about 100% stock price appreciation in recent months, I continue to believe that the company is reasonably valued.

image for news SoFi Technologies: Maintaining Strong Buy On Macro Tailwinds

This Fintech Sold Off Hard After Earnings, But It's Primed For A Big 2025 — Positive

LC   The Motley Fool — February 10, 2025

Popular market analyst Tom Lee of Fundstrat recently called the financial sector his favorite investment for 2025.

image for news This Fintech Sold Off Hard After Earnings, But It's Primed For A Big 2025